Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392:508–20.
Article PubMed PubMed Central Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
Chiarotti F, Venerosi A. Epidemiology of autism spectrum disorders: a review of worldwide prevalence estimates since 2014. Brain Sci. 2020;10:274.
Article PubMed PubMed Central Google Scholar
Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev. 2012;36:2044–55.
Article CAS PubMed PubMed Central Google Scholar
Rubenstein JLR, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems: model of autism. Genes Brain Behav. 2003;2:255–67.
Article CAS PubMed PubMed Central Google Scholar
Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O’Shea DJ, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171–8.
Article CAS PubMed PubMed Central Google Scholar
Rojas DC. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm. 2014;121:891–905.
Article CAS PubMed PubMed Central Google Scholar
Vyas Y, Cheyne JE, Lee K, Jung Y, Cheung PY, Montgomery JM. Shankopathies in the developing brain in autism spectrum disorders. Front Neurosci. 2021;15:775431.
Article PubMed PubMed Central Google Scholar
Eltokhi A, Santuy A, Merchan-Perez A, Sprengel R. Glutamatergic dysfunction and synaptic ultrastructural alterations in schizophrenia and autism spectrum disorder: evidence from human and rodent studies. IJMS. 2020;22:59.
Article PubMed PubMed Central Google Scholar
Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate—serotonin interactions for pharmacotherapy. J Neural Transm. 1998;105:525.
Article CAS PubMed Google Scholar
Fatemi SH. The hyperglutamatergic hypothesis of autism. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32:911.
Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett. 1993;163:53–57.
Article CAS PubMed Google Scholar
Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res. 2006;326:483–504.
Article CAS PubMed Google Scholar
Lee M, Martin GE, Berry-Kravis E, Losh M. A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome. J Neurodev Disord. 2016;8:47.
Article PubMed PubMed Central Google Scholar
Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, et al. Mavoglurant in fragile X syndrome: results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med. 2016;8:1–11.
Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, et al. Effect of the mGluR5-NAM Basimglurant on behavior in adolescents and adults with fragile x syndrome in a randomized, double-blind, placebo-controlled trial: FragXis phase 2 results. Neuropsychopharmacology. 2018;43:503–12.
Article CAS PubMed Google Scholar
Levenga J, Hayashi S, de Vrij FMS, Koekkoek SK, van der Linde HC, Nieuwenhuizen I, et al. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiol Dis. 2011;42:311–7.
Article CAS PubMed Google Scholar
Hagerman R, Jacquemont S, Berry-Kravis E, Des Portes V, Stanfield A, Koumaras B, et al. Mavoglurant in fragile x syndrome: results of two open-label, extension trials in adults and adolescents. Sci Rep. 2018;8:16970.
Article PubMed PubMed Central Google Scholar
Fatemi SH, Folsom TD, Kneeland RE, Liesch SB. Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both fragile x mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat Rec. 2011;294:1635–45.
Fatemi SH, Wong DF, Brašić JR, Kuwabara H, Mathur A, Folsom TD, et al. Metabotropic glutamate receptor 5 tracer [18F]-FPEB displays increased binding potential in postcentral gyrus and cerebellum of male individuals with autism: a pilot PET study. Cerebellum Ataxias. 2018;5:3.
Article PubMed PubMed Central Google Scholar
Brašić JR, Nandi A, Russell DS, Jennings D, Barret O, Martin SD, et al. Cerebral expression of metabotropic glutamate receptor subtype 5 in idiopathic autism spectrum disorder and fragile x syndrome: a pilot study. IJMS. 2021;22:2863.
Article PubMed PubMed Central Google Scholar
Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ. Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol. 2013;106–107:1–16.
Hergueta T, Lecrubier Y, Sheehan D, Weiller E. Mini international neuropsychiatric interview French current DSM-IV. 2015. https://doi.org/10.13140/RG.2.1.2792.9440.
First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis. 2013;201:727–9.
Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659–85.
Article CAS PubMed Google Scholar
Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule–generic: a standard measure of social and communication deficits associated with the spectrum of autism. 2000;30:205–23.
Wechsler D. Echelle d’intelligence de Wechsler pour adultes (WAIS-III). 3ème éd. Paris: ECPA; 2000.
Wechsler D. Echelle d’intelligence de Wechsler pour adultes (WAIS-IV). 4ème éd. Paris: ECPA; 2011.
Schopler E, Lansing MD, Reichler RJ, Marcus LM. PEP-3. Profil psycho-educatif. Evaluation fonctionnelle pour enfants autistes. de BoeckBruxelles, Belgique; 2020.
Barfthelemy C, Roux S, Adrien JL, Hameuiy L, Gtieriis P, Garreau B, et al. Validation of the revised behavior summarized evaluation scale. 1997;27:139–53.
Bourreau Y, Roux S, Gomot M, Bonnet-Brilhault F, Barthélémy C. Validation of the repetitive and restricted behaviour scale in autism spectrum disorders. Eur Child Adolesc Psychiatry. 2009;18:675–82.
Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31:5–17.
Article CAS PubMed Google Scholar
Baron-Cohen S, Wheelwright S. The empathy quotient: an investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. J Autism Dev Disord. 2004;34:163–75.
Dupont A-C, Serrière S, Barantin L, Vercouillie J, Tauber C, Gissot V, et al. Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers. Transl Psychiatry. 2021;11:66.
Article CAS PubMed PubMed Central Google Scholar
Apps MAJ, Lockwood PL, Balsters JH. The role of the midcingulate cortex in monitoring others’ decisions. Front Neurosci. 2013;7:1–7.
Apps MAJ, Rushworth MFS, Chang SWC. The anterior cingulate gyrus and social cognition: tracking the motivation of others. Neuron. 2016;90:692–707.
Article CAS PubMed PubMed Central Google Scholar
Leech R, Sharp DJ. The role of the posterior cingulate cortex in cognition and disease. Brain. 2014;137:12–32.
Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, et al. Methodological consensus on clinical proton MRS of the brain: review and recommendations. Magn Reson Med. 2019;82:527–50.
Article PubMed PubMed Central Google Scholar
Oeltzschner G, Zöllner HJ, Hui SCN, Mikkelsen M, Saleh MG, Tapper S, et al. Osprey: open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. J Neurosci Methods. 2020;343:108827.
Article CAS PubMed PubMed Central Google Scholar
Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med. 2006;55:1219–26.
Article CAS PubMed Google Scholar
Harris AD, Puts NAJ, Edden RAE. Tissue correction for GABA-edited MRS: considerations of voxel composition, tissue segmentation, and tissue relaxations: tissue correction for GABA-Edited MRS. J Magn Reson Imaging. 2015;42:1431–40.
Article PubMed PubMed Central Google Scholar
Gussew A, Erdtel M, Hiepe P, Rzanny R, Reichenbach JR. Absolute quantitation of brain metabolites with respect to heterogeneous tissue compositions in 1H-MR spectroscopic volumes. Magn Reson Mater Phys. 2012;25:321–33.
Truong V, Duncan NW. Suggestions for improving the visualization of magnetic resonance spectroscopy voxels and spectra. R Soc Open Sci. 2020;7:200600.
留言 (0)